BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2523018)

  • 1. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
    Davis ST; Berger SH
    Mol Pharmacol; 1989 Apr; 35(4):422-7. PubMed ID: 2523018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine.
    Davis ST; Berger SH
    Mol Pharmacol; 1993 May; 43(5):702-8. PubMed ID: 8502227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of thymidylate synthase in the response to fluoropyrimidine-folinic acid combinations.
    Berger SH; Davis ST; Barbour KW; Berger FG
    Adv Exp Med Biol; 1988; 244():59-69. PubMed ID: 2977716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthase as a determinant of 5-fluoro-2'-deoxyuridine response in human colonic tumor cell lines.
    Berger SH; Berger FG
    Mol Pharmacol; 1988 Oct; 34(4):474-9. PubMed ID: 2971871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2'-deoxyuridine in a human colon tumor cell line.
    Berger SH; Barbour KW; Berger FG
    Mol Pharmacol; 1988 Oct; 34(4):480-4. PubMed ID: 2971872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for cytosolic folate-binding proteins in the compartmentation of endogenous tetrahydrofolates and the 5-formyl tetrahydrofolate-mediated enhancement of 5-fluoro-2'-deoxyuridine antitumor activity in vitro.
    Matherly LH; Czajkowski CA; Muench SP; Psiakis JT
    Cancer Res; 1990 Jun; 50(11):3262-9. PubMed ID: 2139802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
    Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
    Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in thymidylate synthase confers resistance to 5-fluorodeoxyuridine.
    Hughey CT; Barbour KW; Berger FG; Berger SH
    Adv Exp Med Biol; 1993; 339():67-76. PubMed ID: 8178730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.
    Peters GJ; Smitskamp-Wilms E; Smid K; Pinedo HM; Jansen G
    Cancer Res; 1999 Nov; 59(21):5529-35. PubMed ID: 10554030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells.
    Berger SH; Jenh CH; Johnson LF; Berger FG
    Mol Pharmacol; 1985 Nov; 28(5):461-7. PubMed ID: 2932632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.
    Aschele C; Sobrero A; Faderan MA; Bertino JR
    Cancer Res; 1992 Apr; 52(7):1855-64. PubMed ID: 1532346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
    van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
    Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.
    Sobrero AF; Moir RD; Bertino JR; Handschumacher RE
    Cancer Res; 1985 Jul; 45(7):3155-60. PubMed ID: 3159474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional effects of a naturally occurring amino acid substitution in human thymidylate synthase.
    Hughey CT; Barbour KW; Berger FG; Berger SH
    Mol Pharmacol; 1993 Aug; 44(2):316-23. PubMed ID: 8355668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium leucovorin and 5-fluorouridine cytotoxicity.
    Berger SH; Hakala MT
    J S C Med Assoc; 1990 May; 86(5):284-9. PubMed ID: 2242115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
    van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
    Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diastereoisomers of 5-formyltetrahydrofolate on cellular growth, sensitivity to 5-fluoro-2'-deoxyuridine, and methylenetetrahydrofolate polyglutamate levels in HCT-8 cells.
    Zhang ZG; Rustum YM
    Cancer Res; 1991 Jul; 51(13):3476-81. PubMed ID: 2054787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.